Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) has successfully extinguished its convertible note with Yorkville, clearing the Company’s outstanding debt obligations. CEO David Mehalick stated that this move strengthens the capital structure and prepares the Company for long-term goals. With a streamlined capital structure, Coeptis is now looking to expand into the cryptocurrency space. The Company, consisting of subsidiaries like Coeptis Pharmaceuticals and Coeptis Technologies, focuses on developing innovative cell therapy platforms for various diseases. Coeptis has also established a Technology Division to enhance operational capabilities. For more information, visit their website at https://coeptistx.com.

Read more at GlobeNewswire: Coeptis (COEP) Extinguishes Convertible Note with YA II PN,